PatchTheCVECVE-2026-7485: Incorrect authorization in frozen BI aggregations in Checkmk <2.5.0p2, <2.4.0p29, <2.3.0p47, and all 2.2.0 ver
CVE-2026-7485 is a low-severity flaw (CVSS 2.3) affecting affected software. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Incorrect authorization in frozen BI aggregations in Checkmk <2.5.0p2, <2.4.0p29, <2.3.0p47, and all 2.2.0 versions allows an authenticated user with restricted host and service visibility to learn the names and the existence of hosts and services they are not authorized to see.
Why this priority
- No elevated risk signals yet
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 2.3 (Low) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | None |
| EPSS exploit chance | 0.4% (top 72%) |
| CISA exploited list | No |
| Weakness | CWE-863 |
| Published | 2026-08-20 |
| Last modified | 2026-10-23 |
Last updated 2026-10-23 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2026-7485?
No fixed release is listed yet. Watch the vendor advisory and apply any mitigation shown on this page.
Is CVE-2026-7485 being exploited?
CVE-2026-7485 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2026-7485 affect?
CVE-2026-7485 affects affected software. Severity is low (CVSS 2.3). Incorrect authorization in frozen BI aggregations in Checkmk <2.5.0p2, <2.4.0p29, <2.3.0p47, and all 2.2.0 versions allows an authenticated user with restricted host and service visibility to learn the names and the existence of hosts and s
How urgent is CVE-2026-7485?
Priority 15/100. No elevated risk signals yet.